U.S. markets open in 3 hours 14 minutes

Seer, Inc. (SEER)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.6700+0.0100 (+0.60%)
At close: 04:00PM EST
1.6300 -0.04 (-2.40%)
After hours: 05:02PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close1.6600
Bid0.0000 x 900
Ask0.0000 x 2900
Day's Range1.6398 - 1.6990
52 Week Range1.4550 - 6.7500
Avg. Volume352,106
Market Cap106.588M
Beta (5Y Monthly)1.52
PE Ratio (TTM)N/A
EPS (TTM)-1.4300
Earnings DateFeb 29, 2024 - Mar 04, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for SEER

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Seer, Inc.
    BIO: Lowering target price to $274.00BIO-RAD LABORATORIES-A has an Investment Rating of SELL; a target price of $274.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more
  • Simply Wall St.

    Need To Know: The Consensus Just Cut Its Seer, Inc. (NASDAQ:SEER) Estimates For 2024

    One thing we could say about the analysts on Seer, Inc. ( NASDAQ:SEER ) - they aren't optimistic, having just made a...

  • GlobeNewswire

    Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

    REDWOOD CITY, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the upcoming Canaccord MedTech, Diagnostics and Digital Health and Services Forum in New York, NY. Seer’s management is scheduled to present on Thursday, November 16th at 1:00 p.m. Eastern Time / 10:00 a.m. Pacific Time. A live webcast of the session will be availabl

  • Insider Monkey

    Seer, Inc. (NASDAQ:SEER) Q3 2023 Earnings Call Transcript

    Seer, Inc. (NASDAQ:SEER) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good day, and thank you for standing by. Welcome to the Seer Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised […]